🇺🇸 Paraplatin in United States

15,880 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alopecia — 4,409 reports (27.76%)
  2. Hair Texture Abnormal — 1,885 reports (11.87%)
  3. Hair Colour Changes — 1,884 reports (11.86%)
  4. Hair Disorder — 1,841 reports (11.59%)
  5. Madarosis — 1,738 reports (10.94%)
  6. Psychological Trauma — 1,451 reports (9.14%)
  7. Anxiety — 818 reports (5.15%)
  8. Emotional Distress — 755 reports (4.75%)
  9. Pain — 564 reports (3.55%)
  10. Impaired Quality Of Life — 535 reports (3.37%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Paraplatin approved in United States?

Paraplatin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Paraplatin in United States?

ARCAGY/ GINECO GROUP is the originator. The local marketing authorisation holder may differ — check the official source linked above.